InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by North Annette, Directeur Juridique. Officer active across 1 company, notably Turning Point Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €43k. History available since 6 May 2021. The latest transaction was filed on 9 February 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
669 shares@ US$36.302.3% of flowCommon StockSEC:0001209191-22-008981:0
669 shares@ US$36.304.6% of flowCommon StockSEC:0001209191-22-008981
◇
10,000 shares@ US$17.0015.7% of flowCommon StockSEC:0001209191-21-054117:0
◇
10,000 shares@ US$17.0015.7% of flowCommon StockSEC:0001209191-21-054117
◇
15,000 shares@ US$17.0022.9% of flowCommon StockSEC:0001209191-21-040984
◇
15,000 shares@ US$17.0022.9% of flowCommon StockSEC:0001209191-21-040984:0
5,882 shares@ US$17.009.0% of flowCommon StockSEC:0001209191-21-030925:0
5,882 shares@ US$17.009.0% of flowCommon StockSEC:0001209191-21-030925
8 of 8 declarations
About North Annette
Annette North is the Executive Vice President, General Counsel, and Secretary at Turning Point Therapeutics, Inc. She is responsible for the company's legal affairs and compliance. Annette plays a key role in protecting the legal and regulatory interests of the organization.
